Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension

JM Ritter - BMJ, 2011 - bmj.com
… as A comprise angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor
blockers (ARBs); B drugs are β adrenoceptor antagonists (also known as β blockers) and have …

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney

JM Thurman, RW Schrier - The American journal of medicine, 2003 - Elsevier
Many clinicians are uncomfortable about using angiotensin-converting enzyme (ACE)
inhibitors or angiotensin II type 1 receptor blockers (AT 1 -blockers) to treat patients with renal …

Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta …

G Reboldi, F Angeli, C Cavallini, G Gentile… - Journal of …, 2008 - journals.lww.com
… II receptor blockers are as effective as angiotensin-converting enzyme inhibitors on the
risk … Angiotensin II receptor blockers may be slightly more protective than angiotensin-converting …

Differences in the clinical effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a critical review of the evidence

CA Dézsi - American Journal of Cardiovascular Drugs, 2014 - Springer
… Although both angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor
antagonists (angiotensin receptor blockers; ARBs) are equally important in the treatment of …

A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure

G Savarese, P Costanzo, JGF Cleland… - Journal of the American …, 2013 - jacc.org
… are mediated through stimulation of angiotensin II receptor 1. Angiotensin receptor blockers
(ARBs) prevent angiotensin II receptor 1 stimulation without direct effects on bradykinin/…

Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension

TWR Doulton, FJ He, GA MacGregor - Hypertension, 2005 - Am Heart Assoc
receptor blocker on blood pressure. Proteinuria was reduced by the combination compared
with ACE inhibitor and angiotensin receptor blockerinhibitor-angiotensin receptor blocker

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

JS Healey, A Baranchuk, E Crystal, CA Morillo… - Journal of the American …, 2005 - jacc.org
Objectives : This study was designed to identify all randomized clinical trial data evaluating
angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for the prevention …

COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?

AB Patel, A Verma - Jama, 2020 - jamanetwork.com
… with hypertension is confounded by treatment with specific antihypertensive medications:
angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs). …

Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?

M Böhm - The American journal of cardiology, 2007 - Elsevier
… This article reviews the effects of angiotensin-converting enzyme (ACE) inhibitors and
angiotensin receptor blockers (ARBs) at different stages of the cardiovascular continuum: …

Use of beta‐blockers, angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta‐analysis

S Raimondi, E Botteri, E Munzone… - … journal of cancer, 2016 - Wiley Online Library
… Beta‐blocker (BB) drugs, angiotensin‐converting enzyme inhibitors (ACEi) and angiotensin
receptor blockers (ARB) were suggested to have a favorable role in the development and …